Editorial: Targeting Pancreatic Cancer: Strategies and Hopes

Editorial: Targeting Pancreatic Cancer: Strategies and Hopes

Bibliographic Details
Main Authors:	Kanjoormana Aryan Manu, Kuzhuvelil B. Harikumar, Takatsugu Ishimoto
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Oncology
Subjects:	pancreatic cancer therapeutics tumor microenvironment metastasis nomograms
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.873682/full

Similar Items

Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target
by: Conner Hartupee, et al.
Published: (2024-02-01)

Tumor microenvironment participates in metastasis of pancreatic cancer
by: Bo Ren, et al.
Published: (2018-07-01)

Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
by: Seyed Hossein Kiaie, et al.
Published: (2021-05-01)

Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
by: Chin-King Looi, et al.
Published: (2019-04-01)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
by: Wanxing Duan, et al.
Published: (2022-06-01)

Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
by: Ruiyuan Xu, et al.
Published: (2020-09-01)

Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib
by: Junyeol Kim, et al.
Published: (2024-03-01)

Transcriptome Reprogramming of CD11b+ Bone Marrow Cells by Pancreatic Cancer Extracellular Vesicles
by: Joana Maia, et al.
Published: (2020-11-01)

Prognostic utility of TME-associated genes in pancreatic cancer
by: Yuanhua Nie, et al.
Published: (2023-09-01)

TAMing pancreatic cancer: combat with a double edged sword
by: Manendra Babu Lankadasari, et al.
Published: (2019-03-01)

Collagenase-Expressing <i>Salmonella</i> Targets Major Collagens in Pancreatic Cancer Leading to Reductions in Immunosuppressive Subsets and Tumor Growth
by: Nancy D. Ebelt, et al.
Published: (2021-07-01)

Pancreatic Stellate Cells and the Targeted Therapeutic Strategies in Chronic Pancreatitis
by: Man Chang, et al.
Published: (2023-07-01)

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma
by: Jia-Hao Zheng, et al.
Published: (2022-10-01)

Inflammation-Induced Tumorigenesis and Metastasis
by: Sana Hibino, et al.
Published: (2021-05-01)

Pancreatic Cancer and Microenvironments: Implications of Anesthesia
by: Hou-Chuan Lai, et al.
Published: (2022-05-01)

Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies
by: Anna Linehan, et al.
Published: (2024-03-01)

Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort study
by: Ruobing Wang, et al.
Published: (2022-10-01)

Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context
by: Samuel A Kerk, et al.
Published: (2022-07-01)

The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways
by: Chao Yin, et al.
Published: (2022-05-01)

Immunotherapy, Radiotherapy, and Hyperthermia: A Combined Therapeutic Approach in Pancreatic Cancer Treatment
by: Javed Mahmood, et al.
Published: (2018-11-01)

The tumor–stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinoma
by: Mei Lu, et al.
Published: (2023-07-01)

An Organotypic Microcosm for the Pancreatic Tumor Microenvironment
by: Miranda Lin, et al.
Published: (2020-03-01)

Large-Section Histopathology Can Better Indicate the Immune Microenvironment and Predict the Prognosis of Pancreatic Ductal Adenocarcinoma Than Small-Section Histopathology
by: Guiling Ding, et al.
Published: (2021-07-01)

Development and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort study
by: He C, et al.
Published: (2019-05-01)

The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
by: Yang Wu, et al.
Published: (2021-01-01)

Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer
by: Li-Hong He, et al.
Published: (2023-04-01)

Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
by: Bolun Jiang, et al.
Published: (2020-10-01)

Editorial: Reviews in gastrointestinal cancers
by: Kanjoormana Aryan Manu, et al.
Published: (2023-07-01)

Molecular mechanism and potential therapeutic targets of liver metastasis from gastric cancer
by: Difeng Li, et al.
Published: (2022-11-01)

The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer
by: Ana S. Leal, et al.
Published: (2020-12-01)

The emerging role of neutrophil extracellular traps in cancer: from lab to ward
by: Wentao Zhong, et al.
Published: (2023-04-01)

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer
by: Weiyu Ge, et al.
Published: (2022-12-01)

The Role of Autophagy in Pancreatic Cancer: From Bench to the Dark Bedside
by: Kıvanç Görgülü, et al.
Published: (2020-04-01)

Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
by: Daiyong Deng, et al.
Published: (2022-09-01)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
by: Ying Li, et al.
Published: (2023-03-01)

Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications
by: Xinyang Zhong, et al.
Published: (2022-11-01)

Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia
by: Friederike V. Opitz, et al.
Published: (2021-12-01)

Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
by: Jingshu Tong, et al.
Published: (2022-11-01)

An Update on Gemcitabine-Based Chemosensitization Strategies in Pancreatic Ductal Adenocarcinoma
by: Tianpeng Zhang, et al.
Published: (2023-12-01)

Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancers
by: Yawei Qian, et al.
Published: (2023-10-01)